IBM의 AI Watson의 실패를 조명한 N | 커리어리

IBM의 AI Watson의 실패를 조명한 NYT 기사 What Ever Happened to IBM’s Watson? by NYT - 클라우드컴퓨팅 및 AI 잘 하고 있는 경쟁사 대비 성과 부진: Watson has not remade any industries. And it hasn’t lifted IBM’s fortunes. The company trails rivals that emerged as the leaders in cloud computing and A.I. — Amazon, Microsoft and Google. While the shares of those three have multiplied in value many times, IBM’s stock price is down more than 10 percent since Watson’s “Jeopardy!” triumph in 2011. - 경영진이 기술보다는 서비스나 마케팅 쪽이었던 것도 실패 요인: The company’s top management was dominated until recently by executives with backgrounds in services and sales rather than technology product experts. - 헬스케어 산업을 겨냥한 것도 효과적이지 못했음: A Health Care ‘Moon Shot’: But it turned out to be not useful or flexible enough to be a winning product. At the end of last year, IBM discontinued Watson for Genomics, which grew out of the joint research with the University of North Carolina. It also shelved another cancer offering, Watson for Oncology, developed with another early collaborator, the Memorial Sloan Kettering Cancer Center.

What Ever Happened to IBM's Watson?

Nytimes

2021년 7월 30일 오전 11:30

댓글 0

주간 인기 TOP 10

지난주 커리어리에서 인기 있던 게시물이에요!

더 많은 인사이트를 둘러보세요!